Search
Acurx Pharmaceuticals Inc
ACXPAdd to Watchlist
1.410USD
+0.020+1.44%
Market hours 09/18, 11:23（ET）
6.60MMarket Cap
LossP/E TTM
Acurx Pharmaceuticals Inc (ACXP) Stock Price Target & Forecast
Analyst Rating
Based on 3 analysts giving stock ratings to Acurx Pharmaceuticals Inc in the past month.
Buy
0 Strong Buy
3 Buy
0 Hold
0 Sell
0 Strong Sell
Target Price
17.000USD+1154.61%
ACXP Analyst Recommendation Trends
In the current month, ACXP has received 3 Buy Ratings, 0 Hold Ratings, and 0 Sell Ratings. ACXP average Analyst price target in the last month is 17.000.
2026-09
2026-08
2026-07
2026-06
2026-05
2026-04
2026-03
2026-02
0
0
0
0
0
0
0
0
3
3
3
3
3
3
3
3
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
3
3
3
3
3
3
3
3
Financial Forecasting
Based on analysts' estimates, ACXP EPS is projected to reach -0.377 in FY2026Q3, following reported EPS of -0.529 in FY2026Q2. Track earnings expectations against reported figures to see how profitability is evolving.
EPS
Revenue
Net Profit
EBIT
Forecast
Actual
FY2025Q4
FY2026Q1
FY2026Q2
FY2026Q3
FY2026Q4
Forecast
-0.99
-0.64
-0.38
-0.38
-0.36
Actual
-0.73
-0.62
-0.53
--
--
Surprise
+26.85%
+2.62%
-40.50%
--
--
FAQs
What is Acurx Pharmaceuticals Inc's price target?
Analysts forecast that Acurx Pharmaceuticals Inc's price target is USD 30.50, with the highest forecast at USD 165.80 and the lowest forecast at USD 20.00.
How have Acurx Pharmaceuticals IncACXP's recent earnings per share performed?
The market expectation was USD -0.53, while Acurx Pharmaceuticals IncACXP's earnings per share (EPS) for the previous quarter was USD -0.62. EPS for the next quarter is expected at USD -0.38.
What is the analyst rating for Acurx Pharmaceuticals Inc?
Based on the ratings of Acurx Pharmaceuticals Inc's stock from 3 analysts, most analysts support a Buy trend. After considering the opinions of other analysts, we ultimately rate Apple's stock as Buy. Please note that this is not trading advice. You still need to conduct your own analysis.